BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38587579)

  • 1. Rutin alleviates Sjogren's syndrome via CaR/NLRP3/NF-κB signal pathway.
    He J; Xu M; Wu S
    In Vitro Cell Dev Biol Anim; 2024 Apr; 60(4):411-419. PubMed ID: 38587579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Huoxue Jiedu Recipe represses mitochondrial fission to alleviate submandibular gland inflammation in Sjögren's syndrome.
    Xu J; Shen Z; Du Y; Zhang S; Xi Y; Zhang Y; Wang D; Zhu Y
    Microbiol Immunol; 2023 Aug; 67(8):377-387. PubMed ID: 37340676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. USP5 negatively regulates the activation of NLRP3 inflammasomes and participates in the pathological and physiological processes of Sjogren's syndrome.
    He J; Chen Y; Xu M; Wu S
    Int Immunopharmacol; 2024 Jun; 135():112274. PubMed ID: 38772301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total glucosides of paeony alleviates experimental Sjögren's syndrome through inhibiting NLRP3 inflammasome activation of submandibular gland cells.
    Jiang T; Guo J; Wang Y; Wu H; Chen Y; Wang S; Zhang H; Long Q; Yao G
    Clin Exp Rheumatol; 2023 Dec; 41(12):2502-2510. PubMed ID: 38149512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P2X7 receptor antagonism prevents IL-1β release from salivary epithelial cells and reduces inflammation in a mouse model of autoimmune exocrinopathy.
    Khalafalla MG; Woods LT; Camden JM; Khan AA; Limesand KH; Petris MJ; Erb L; Weisman GA
    J Biol Chem; 2017 Oct; 292(40):16626-16637. PubMed ID: 28798231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total glucosides of paeony (TGP) alleviates Sjogren's syndrome through inhibiting inflammatory responses in mice.
    Li B; Liu G; Liu R; He S; Li X; Huang L; Wang Z; Li Y; Chen Y; Yin H; Fang W
    Phytomedicine; 2020 Jun; 71():153203. PubMed ID: 32402913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary mucins induce a Toll-like receptor 4-mediated pro-inflammatory response in human submandibular salivary cells: are mucins involved in Sjögren's syndrome?
    Barrera MJ; Aguilera S; Veerman E; Quest AF; Díaz-Jiménez D; Urzúa U; Cortés J; González S; Castro I; Molina C; Bahamondes V; Leyton C; Hermoso MA; González MJ
    Rheumatology (Oxford); 2015 Aug; 54(8):1518-27. PubMed ID: 25802401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of cAMP-PKA Signaling Pathway Mediated by Shaoyao Gancao Decoction () on Regulation of Aquaporin 5 and Muscarinic Receptor 3 Levels in Sjögren's Syndrome.
    Wang D; Zhao H; Li B; Sun Y; Wei DH
    Chin J Integr Med; 2020 Jul; 26(7):502-509. PubMed ID: 32632716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P2Y2 nucleotide receptor up-regulation in submandibular gland cells from the NOD.B10 mouse model of Sjögren's syndrome.
    Schrader AM; Camden JM; Weisman GA
    Arch Oral Biol; 2005 Jun; 50(6):533-40. PubMed ID: 15848146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cevimeline on the immunolocalization of aquaporin-5 and the ultrastructure of salivary glands in Sjögren's syndrome model mice.
    Nishimura H; Yakeishi A; Saga T; Yamaki K
    Kurume Med J; 2009; 56(3-4):39-47. PubMed ID: 20505281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoactive intestinal peptide/vasoactive intestinal peptide receptor relative expression in salivary glands as one endogenous modulator of acinar cell apoptosis in a murine model of Sjögren's syndrome.
    Hauk V; Calafat M; Larocca L; Fraccaroli L; Grasso E; Ramhorst R; Leirós CP
    Clin Exp Immunol; 2011 Dec; 166(3):309-16. PubMed ID: 22059987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local suppression of IL-21 in submandibular glands retards the development of Sjögren's syndrome in non-obese diabetic mice.
    Liu H; Liu G; Gong L; Zhang Y; Jiang G
    J Oral Pathol Med; 2012 Nov; 41(10):728-35. PubMed ID: 22643047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of total glucosides of peony on AQP-5 and its mRNA expression in submandibular glands of NOD mice with Sjogren's syndrome.
    Wu GL; Pu XH; Yu GY; Li TY
    Eur Rev Med Pharmacol Sci; 2015 Jan; 19(1):173-8. PubMed ID: 25635992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the alternative NFκB pathway improves disease symptoms in a model of Sjogren's syndrome.
    Gilboa-Geffen A; Wolf Y; Hanin G; Melamed-Book N; Pick M; Bennett ER; Greenberg DS; Lester S; Rischmueller M; Soreq H
    PLoS One; 2011; 6(12):e28727. PubMed ID: 22174879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qing Zao Fang (QZF) Alleviates the Inflammatory Microenvironment of the Submandibular Gland in Sjögren's Syndrome Based on the PI3K/Akt/HIF-1
    Zeng P; Liu W; Yang X; Zhang S; Du S; Fan Y; Zhao L; Wang A
    Dis Markers; 2022; 2022():6153459. PubMed ID: 35140821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artesunate inhibits Sjögren's syndrome-like autoimmune responses and BAFF-induced B cell hyperactivation via TRAF6-mediated NF-κB signaling.
    Zhan T; Wang B; Fu J; Shao Y; Ye L; Shi H; Zheng L
    Phytomedicine; 2021 Jan; 80():153381. PubMed ID: 33086170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low salivary dehydroepiandrosterone and androgen-regulated cysteine-rich secretory protein 3 levels in Sjögren's syndrome.
    Laine M; Porola P; Udby L; Kjeldsen L; Cowland JB; Borregaard N; Hietanen J; Ståhle M; Pihakari A; Konttinen YT
    Arthritis Rheum; 2007 Aug; 56(8):2575-84. PubMed ID: 17665393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice.
    Nguyen CQ; Hu MH; Li Y; Stewart C; Peck AB
    Arthritis Rheum; 2008 Mar; 58(3):734-43. PubMed ID: 18311793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunohistochemistry-based study on aquaporin (AQP)-1, 3, 4, 5 and 8 in the parotid glands, submandibular glands and sublingual glands of Sjögren's syndrome mouse models chronically administered cevimeline.
    Nakamura M; Saga T; Watanabe K; Takahashi N; Tabira Y; Kusukawa J; Yamaki K
    Kurume Med J; 2013; 60(1):7-19. PubMed ID: 23925155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CP-25 alleviates antigen-induced experimental Sjögren's syndrome in mice by inhibiting JAK1-STAT1/2-CXCL13 signaling and interfering with B-cell migration.
    Wu H; Chen X; Gu F; Zhang P; Xu S; Liu Q; Zhang Q; Wang X; Wang C; Körner H; Wei W
    Lab Invest; 2021 Aug; 101(8):1084-1097. PubMed ID: 32620868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.